Bausch Health resolves IBS patent litigation

07-05-2020

Sarah Morgan

Bausch Health resolves IBS patent litigation

Kate Krav-Rude / Shutterstock.com

Canada-based Bausch Health has agreed to settle its dispute with generic maker Sandoz over the latter’s attempt to release a generic version of antibiotic Xifaxan (Rifaximin).


Xifaxan, Bausch Health, Sandoz, generics, IBS, antibiotic, litigation, settlement, patent infringement.

LSIPR